Detalles de la búsqueda
1.
Interdisciplinary pharmacometrics linking oseltamivir pharmacology, influenza epidemiology and health economics to inform antiviral use in pandemics.
Br J Clin Pharmacol
; 83(7): 1580-1594, 2017 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28176362
2.
A phase 2 trial of R1507, a monoclonal antibody to the insulin-like growth factor-1 receptor (IGF-1R), in patients with recurrent or refractory rhabdomyosarcoma, osteosarcoma, synovial sarcoma, and other soft tissue sarcomas: results of a Sarcoma Alliance for Research Through Collaboration study.
Cancer
; 120(16): 2448-56, 2014 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-24797726
3.
Safety, tolerability, and pharmacokinetics of intravenous oseltamivir: single- and multiple-dose phase I studies with healthy volunteers.
Antimicrob Agents Chemother
; 56(9): 4729-37, 2012 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-22733065
4.
Effect of Food and Esomeprazole on the Pharmacokinetics of Alectinib, a Highly Selective ALK Inhibitor, in Healthy Subjects.
Clin Pharmacol Drug Dev
; 6(4): 388-397, 2017 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-27545320
5.
Clinical Drug-Drug Interactions Through Cytochrome P450 3A (CYP3A) for the Selective ALK Inhibitor Alectinib.
Clin Pharmacol Drug Dev
; 6(3): 280-291, 2017 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-27545757
6.
Effect of the Wetting Agent Sodium Lauryl Sulfate on the Pharmacokinetics of Alectinib: Results From a Bioequivalence Study in Healthy Subjects.
Clin Pharmacol Drug Dev
; 6(3): 266-279, 2017 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-27545871
7.
Pharmacokinetics and safety of coadministered oseltamivir and rimantadine in healthy volunteers: an open-label, multiple-dose, randomized, crossover study.
J Clin Pharmacol
; 52(8): 1255-64, 2012 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-22039289
Resultados
1 -
7
de 7
1
Próxima >
>>